Amoxi-Tabs C®-250 broad-spectrum antibiotic with bacterial resistance inhibitor

Amoxi-Tabs C®-250

Broad-spectrum antibiotic with bacterial resistance inhibitor

Canines Felines Tablet Oral

Amoxicillin base 200 mg, clavulanic acid 50 mg; excipients q.s. ad 1 tablet.

For the treatment of periodontal infections caused by susceptible strains (aerobic and anaerobic bacterias). Treatment of skin and soft tissues infections caused by susceptible species of Staphylococcus spp. E. coli, Pasteurella spp. and Streptococcus spp. Treatment of respiratory tract and urinary tract infections, including those caused by susceptible species of E. coli. Osteomyelitis treatment and other bacterial complications susceptible to amoxicillin.

1 tablet/16 kg every 8 - 12 hours for at least 3 days. Administer through oral route.
Box x 10 tablets , Box x 50 tablets ,

SENASA Registry: SENASA Perú: F.83.31.I.0025

This content is informative reference and should not be considered as prescriptions.

You may also be interested

Liquacef® C
Liquacef® C
Last Generation Cephalosporin Antibiotic with Bacterial Resistance Inhibitor and Long Mean Life
Powder for Oral Suspension
Liquamox® C
Liquamox® C
Broad-spectrum beta-lactam antibiotic with bacterial resistance inhibitor
Powder for Oral Suspension